IPF treatment candidate CS014 was safe and well tolerated in volunteers in a Phase 1 trial, and showed early promise for ...

A flash flood can pose unique risks for PF patients, says columnist Sam Kirton, who shares several ways to prepare for such an emergency.

Taladegib has been granted orphan drug designation in the U.S. and the European Union as a treatment for idiopathic pulmonary ...

Looking for information on Shallow Breathing (Tachypnea) in pulmonary fibrosis? Read about breathing alterations in IPF here.

Fatigue, sometimes described as overwhelming tiredness or physical malaise, is a common symptom of pulmonary fibrosis (PF) patients. Generally, fatigue is characterized by a lack of energy that does ...

Pulmonary fibrosis (PF) is characterized by the formation of scar tissue in the lungs, which impairs their normal function and makes it harder for oxygen to reach the bloodstream. Despite varying from ...